Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

GrowGeneration Corp

The U.S. Department of Health and Human Services just recommended easing regulations on marijuana. The U.S. Drug Enforcement Agency may (or may not) take that advice.

Why Marijuana Stocks Are Glowing Green on Thursday

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Trulieve Cannabis Corp.

Tilray Brands

The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many questions remain.

HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain

Aurora Cannabis

Cannabis stocks are up on Thursday as investors in the market react to news marijuana may be downgraded from a Schedule I drug. According to insiders, a member of the Department of Health and Human Services is seeking a drop in the drug from Schedule I to Schedule III.

Why Are Cannabis Stocks TLRY, ACB, CGC, CURLF Up Today?

Cronos Group

OrganiGram Holdings Inc.

Shares of marijuana companies climbed as much as 14% in morning trading on Thursday after the Department of Health and Human Services recommended its reclassification as a lower-risk substance following an 11-month review.

Pot firms gain as US move to ease curbs boosts sentiment

Innovative Industrial Properties

SNDL Inc.

The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug, reviving hope among investors and marijuana producers for an industry that took off like a rocket five years ago before sinking like a rock less than two years later.

Will a Change to US Marijuana Policy Save Any of the Weed Companies?

Canopy Growth issued 15.2 million common shares to Les Serres Stephane Bertrand as part of an amended agreement for the Canadian cannabis company to buy a 45% stake in Les Serres Vert Cannabis.

Canopy Growth amends agreement to buy remaining stake of Les Serres Vert Cannabis

According to a media report, a top federal health official has formally requested the reclassification of marijuana. This indicates high-level government support for drug law reform, at least for cannabis.

Why Canopy Growth Stock Was on Fire Today

Roundhill Cannabis ETF

The Drug Enforcement Agency received an official recommendation to downgrade marijuana.  Currently, pot is classified as a Schedule I drug, on par with heroin.

Pot stocks jump as federal agency reportedly seeks to downgrade cannabis from the hard-drug category

That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.

HHS calls for easing restrictions on marijuana, sending cannabis stocks higher

The U.S. Department of Health and Human Services is recommending to the U.S. Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under U.S. law from Schedule I now, according to a report by Bloomberg. Cannabis stocks are rallying, with the AdviserShares Pure US Cannabis ETF MSOS, +18.76% up by nearly 33%, and the ETFMG Alternative Harvest ETF MJ, +10.27% up by 19.5%.

U.S. Dept. of Health and Human Services recommends re-scheduling cannabis, as stocks in the sector rally

WM Technology

Marijuana stock investors are consistently on watch for a rise in trading. The cannabis sector is an area of the stock market with more volatile trading than others. What this means is that without warning the way a stock trades can change. Now this can be both positive and negative depending on who you are and how you feel about the legal cannabis market. Like any other stock, you want to find the lowest price point to take up a position.

Top Marijuana Stocks To Watch Right Now 2023

AdvisorShares, the company managing the world's largest hemp exchange-traded fund Poseidon Dynamic Cannabis ETF (NYSEARCA:PSDN), has reported a waning interest in cannabis stocks. The cannabis industry in the U.S. faces harsh realities of supply surplus, declining wholesale prices, stricter regulations, and distribution challenges.

3 Undervalued Cannabis Stocks With Sky-High Return Potential

High Tide

Jazz Pharmaceuticals

I will attempt to assess and rank the relative growth potential of the separate competitors in the industry. The industry faces multiple catalysts and is trading near 52-week lows. The cannabis ETFs are full of cash burning companies, so I am forced to research my own basket of stocks.

Finding The Long-Term Winners In The Cannabis Sector, August 2023 Update

Bank of America

Disney

General Motors

Hershey

Icahn Enterprises

Target

Winners and losers emerge from every earnings season. And this year's second quarter has been no different.

7 Stocks Sitting At 52-Week Lows Right Now

Constellation Brands

Molson Coors Brewing

The number of adults age 34 and younger who say they drink alcoholic beverages has dropped during a period of rising cannabis use, according to new survey from Gallup.

Alcohol use drops among young adults, while cannabis consumption grows: Gallup poll

Tilray's global presence could help it thrive as the global cannabis market evolves. Canopy Growth, once a hot cannabis stock, appears to be struggling.

Better Buy: Tilray vs. Canopy Growth

Leafly Holdings

Neptune Wellness Solutions Inc.

Welcome to this week's study of the top marijuana stocks under $1, which are positioned for big gains in August 2023. As the cannabis sector evolves, knowledgeable investors look for possibilities while considering risk. This paper blends technical analysis with insights from the growing cannabis sectors of the United States and Canada.

Top Performing Cannabis Penny Stocks Under $1 in the Past Week

Canopy Growth has been the worst-performing cannabis stock, but there are signs of a potential turnaround. The company is focusing on the US cannabis market and implementing cost-cutting measures to improve its bottom line. The increasing legalization of cannabis in the U.S. and the potential passage of the SAFE Banking Act could benefit Canopy Growth.

Canopy Growth: Buy This Cannabis Stock Before Legalization

SMITHS FALLS, ON , Aug. 18, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) announced today that the Company will hold its 2023 Annual General and Special Meeting in a virtual format. The meeting will begin at 1:00 PM ET on September 25, 2023, and will be conducted by live audio webcast at www.virtualshareholdermeeting.com/WEED2023.

Canopy Growth to Hold Virtual Annual General and Special Meeting of Shareholders

The Canadian marijuana company announced its latest property divestment. It is selling its headquarters building to its former owner, Hershey Canada.

Why Canopy Growth Stock Zoomed Higher Today

Canopy Growth Corporation (TSX:WEED, NYSE:CGC)'s Toronto-listed shares moved lower in pre-market trade on Thursday after the cannabis company announced it will be selling its Hershey Drive facility located in Smiths Falls, Ontario, to Hershey Canada for C$53 million. The sale is part of the company's strategy to move to a simplified, asset-light operating model with greater agility and less execution risk, the company noted.

Canopy Growth sells Hershey Drive Facility for C$53M in pursuit of asset-light strategy

Canopy Growth's revenue increased in the first quarter of fiscal 2024. It reduced its losses significantly in the first quarter.

Canopy Growth Stock: Bear vs. Bull

Canopy Growth Corp.'s CGC, -0.39% U.S.-listed stock fell 1% after the company said it agreed to sell its Hershey Drive facility in Smiths Falls, Ontario to Hershey Co. HSY, -0.56% for C$53 million ($39.3 million). The company will still own its post-harvest manufacturing facility in Smiths Falls.

Canopy Growth selling Smiths Falls facility to Hershey

Facility will be sold to Hershey Canada, Inc. for approximately CAD$53 million Canopy Growth continues to execute on transformation to simplified, asset-light operating model SMITHS FALLS, ON , Aug. 17, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) announced today that it has entered into an agreement (the "Agreement") to sell its Hershey Drive facility (the "Facility") in Smiths Falls, Ontario, as part of the Company's transformation to a simplified, asset-light operating model. Canopy Growth will retain its Smiths Falls-based post-harvest manufacturing facility.

Canopy Growth Enters into an Agreement for the Sale of Hershey Drive Facility in Smiths Falls

Canopy Growth didn't have any mammoth impairment charges weighing down its business this past quarter. Revenue growth, however, remains a challenge as many of the company's segments posted underwhelming numbers.

Canopy Growth Significantly Shrinks Its Loss in Q1: Is Now the Time to Buy?

News for Canopy Growth Stock (CGC)